Author of the publication

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , and . Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 21 (1): 134–147 (2012)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), , , , , , , , , and 123 other author(s). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 21 (1): 134–147 (2012)Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers, , , , , , , , , and 34 other author(s). Human molecular genetics, 19 (14): 2886–2897 (2010)Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers, , , , , , , , , and 99 other author(s). Human molecular genetics, 20 (23): 4732–4747 (2011)Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers, , , , , , , , , and 169 other author(s). Human molecular genetics, 20 (16): 3304–3321 (2011)Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers, , , , , , , , , and 63 other author(s). Breast cancer research : BCR, 12 (6): R102 (2010)RAD51 135G--C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies, , , , , , , , , and 69 other author(s). American journal of human genetics, 81 (6): 1186–1200 (2007)Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk, , , , , , , , , and 252 other author(s). PLoS genetics, 9 (3): e1003212 (2013)Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2, , , , , , , , , and 172 other author(s). Breast cancer research : BCR, 13 (6): R110 (2011)A BRCA1 promoter variant (rs11655505) and breast cancer risk, , , , , , , , , and 8 other author(s). Journal of medical genetics, 47 (4): 268–270 (2010)Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers, , , , , , , , , and 76 other author(s). American journal of human genetics, 82 (4): 937–948 (2008)